Search for Clinical Trial Results

Sponsored By

Hurthle Cell Thyroid Cancer - 3 Studies Found

Status Study
Recruiting Study Name: Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Condition: Refractory Hurthle Cell Thyroid Cancer
Date: 2014-05-19
Interventions:
  • Drug: sorafenib Given PO
Recruiting Study Name: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Date: 2011-07-06
Interventions: Radiation: I131 1.1 GBq Radio-iodine Other Name: Sod
Completed Study Name: A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
Condition: Thyroid Cancer
Date: 2005-07-12
Interventions: Drug: AMG 706